The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity
| Image |  |
|---|---|
| Description | scientific article published on 04 April 2022 |
| Author/s |
author: Derek T. Logan Stacey R Dillon Björn Walse Raymond Kimbung Stanford L Peng |
| Publication date | April 4, 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |